Immuneering Corp (IMRX)
2.17
+0.06
(+2.84%)
USD |
NASDAQ |
Nov 22, 11:00
Immuneering Total Assets (Quarterly): 68.56M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 68.56M |
| June 30, 2024 | 77.09M |
| March 31, 2024 | 87.98M |
| December 31, 2023 | 102.58M |
| September 30, 2023 | 113.88M |
| June 30, 2023 | 124.90M |
| March 31, 2023 | 107.70M |
| December 31, 2022 | 122.37M |
| Date | Value |
|---|---|
| September 30, 2022 | 133.69M |
| June 30, 2022 | 142.05M |
| March 31, 2022 | 152.45M |
| December 31, 2021 | 166.70M |
| September 30, 2021 | 164.04M |
| June 30, 2021 | 53.04M |
| March 31, 2021 | 32.86M |
| December 31, 2020 | 38.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
32.86M
Minimum
Mar 2021
166.70M
Maximum
Dec 2021
105.52M
Average
110.79M
Median
Total Assets (Quarterly) Benchmarks
| Singular Genomics Systems Inc | 186.55M |
| Biomarin Pharmaceutical Inc | 6.851B |
| Integra Lifesciences Holdings Corp | 4.066B |
| Eton Pharmaceuticals Inc | 35.84M |
| Tenon Medical Inc | 13.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.84M |
| Shareholders Equity (Quarterly) | 57.72M |